(Q41940021)

English

Reversed chloroquines based on the 3,4-dihydropyrimidin-2(1H)-one scaffold: synthesis and evaluation for antimalarial, beta-haematin inhibition, and cytotoxic activity

scientific article published on November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Reversed chloroquines based on the 3,4-dihydropyrimidin-2(1H)-one scaffold: synthesis and evaluation for antimalarial, beta-haematin inhibition, and cytotoxic activity (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

0 references

0 references

6

object named as

Kelly Chibale

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

author name string

Natasha October

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Nicholas D Watermeyer

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Vanessa Yardley

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Timothy J Egan

4

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Kanyile Ncokazi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

1649-1653

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Drug resistance in malaria

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

21 January 2018

The economic and social burden of malaria

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

The challenge of chloroquine-resistant malaria in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel Alkaloids from the Sponge Batzella sp.: Inhibitors of HIV gp120-Human CD4 Binding

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimalarial activity of trioxaquine derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800172

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.200800172

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41940021&oldid=1930089639"